Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:16:12.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed notices about government funding lapse and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T02:07:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide maintenance notice regarding funding lapse and current operating status with links to cc.nih.gov and opm.gov. Updated the page revision identifier to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T00:00:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary visibility was added, change highlights use green for additions and red for deletions, and the revision label was updated from v3.3.4 to v3.4.0 with updated No FEAR Act wording.
    Difference
    0.5%
    Check dated 2026-01-28T00:17:25.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed, indicating a minor system update to the page's revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T17:55:43.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page history. The HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:43:48.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.